அறிவாற்றல் சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவாற்றல் சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவாற்றல் சிகிச்சை இன்க் Today - Breaking & Trending Today

Down Syndrome Market To Hit Smashing Growth focusing on Top Companies | OPKO Health, Inc., LuMind ID


Search jobs
13-May-2021
Down Syndrome Market To Hit Smashing Growth focusing on Top Companies | OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S
The large scale Down Syndrome Market report identifies and analyses the emerging trends along with key drivers, challenges and opportunities in the industry. Moreover, this market report gives idea to clients about the market drivers and restraints extracted from SWOT analysis and also provides all the CAGR projections for the historic year 2018, base year 2019 and forecast period of 2020-2027. Market analysis included here gives an examination of various segments that are relied upon to witness the fastest development amid the estimate forecast frame. And not to mention, before giving it to the end users, all this information is assessed and validated by the market experts. ....

United States , Route Of Administration Oral , Health Inc , Pfizer Inc , Cognition Therapeutics Inc , Johnson Services Inc , Bayer Ag , Zynerba Pharmaceuticals Inc , National Institutes Of Health , Ligand Pharmaceuticals Incorporated , Jalana Center , Transition Therapeutics Inc , Annovis Bio Inc , Genentech Inc , Healthcare Inc , Eisai Co Ltd , Market Research , Promega Corporation , Route Of Administration , Down Syndrome Market , Global Down Syndrome , Sample Report , All Related Graphs , North America , South America , Middle East ,

Cognition Therapeutics Announces Election of Jack Khattar Chairman of the Board


Published: Apr 20, 2021
Pittsburgh, April 20, 2021 (GLOBE NEWSWIRE) Cognition Therapeutics Inc., a clinical stage neuroscience company developing drugs that treat degenerative disorders by regulating cellular damage response pathways, announced that the board of directors has elected Jack A. Khattar chairman of the board. Mr. Khattar, the founder and CEO of Supernus Pharmaceuticals, was appointed in 2020 to serve as a member of the Cognition board of directors. He replaces former chairman, Robert J. Gailus, who has retired from the board of directors. 
“Even in the short time that he has been a member of the board, Jack’s contributions have been significant. As chairman, we will draw more heavily on Jack’s expertise as we pursue a growing repertoire of indications and clinical plans,” stated President and CEO Lisa Ricciardi, “Bob’s retirement from the board comes after a remarkable tenure. He was one of Cognition’s earliest angel investors and continu ....

Lisa Ricciardi , Jacka Khattar , Robertj Gailus , National Institute On , Supernus Pharmaceuticals , Cognition Therapeutics Inc , Therapeutics Inc , Cognition Therapeutics , National Institute , Cognition Therapeutic , ஜாக்கா காட்டார் , தேசிய நிறுவனம் ஆன் , அறிவாற்றல் சிகிச்சை இன்க் , சிகிச்சை இன்க் , அறிவாற்றல் சிகிச்சை , தேசிய நிறுவனம் ,